AzTrials
AzTrials

Early MobilizationNCT06405529

Rehabilitation of Patients From the ICU to the Post-hospital Phase

A study testing Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge in people with Early Mobilization and Physiotherapy, run by University of Sao Paulo.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

Introduction: Advances in knowledge have contributed to the increase in the number of patients who survive prolonged hospitalization in an Intensive Care Unit (ICU), and, among them, critically ill patients who develop acute respiratory failure and need for mechanical ventilation. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Early Mobilization, Physiotherapy, Rehabilitation
What is being tested?
Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge
Could I receive a placebo?
No, everyone receives an active treatment
How many people
206 participants
Where
No sites listed yet
Study dates
1 Jul 2024to 31 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Both sexes
  • Age greater than or equal to 21 years
  • Be on invasive mechanical ventilation (IMV) for at least 48 hours
  • Sufficient cardiovascular stability for mobilization
  • Absence of bradyarrhythmia (< 50 bpm);
  • Heart rate ≥ 150 bpm;
Show all 10Show fewer
  • Most recent lactate measurement ≤ 4.0mmol/L;
  • Combined adrenaline/noradrenaline infusion rate ≤ 0.2mcg/Kg/min, OR if the adrenaline/noradrenaline infusion was increased by more than 25% in the last 6 hours;
  • Cardiac index ≥ 2.0L/min/m2; when evaluated
  • Respiratory stability sufficient for mobilization f) Respiratory rate ≤ 45rpm; g) FiO2 ≤ 0.6; h) PEEP ≤ 16 cmH2O; i) No need for NO (nitric oxide), prone position, neuromuscular blocker, ECMO (extracorporeal membrane oxygenation) or HFOV (high frequency ventilation).

Who cannot join

  • Dependent for ADLs in the month prior to ICU admission;
  • Diagnosed cognitive deficit;
  • Diagnosis OR suspicion of acute primary brain disease (TBI, stroke);
  • Diagnosis OR suspected spinal cord injury OR other neuromuscular disease that may result in prolonged or permanent muscle weakness (except muscle weakness acquired in the ICU);
  • Need OR instructions to remain in bed OR not to bear weight on the lower limbs bilaterally;
  • Life expectancy of less than 180 days due to acute or chronic clinical conditions;
Show all 11Show fewer
  • Death considered inevitable due to current clinical condition or if the patient/clinical guardian is not committed to complete active treatment (e.g. brain death);
  • Inability to communicate in Portuguese;
  • Readmission to the ICU of the same hospital service;
  • Pregnant women;
  • Patients with a permanent pacemaker.

About this study

Official title: Rehabilitation of Patients Submitted to Mechanical Ventilation, From the ICU to the Post-hospital Phase: Blinded Randomized Controlled Clinical Trial, With Economic and Multicenter Evaluation

Introduction: Advances in knowledge have contributed to the increase in the number of patients who survive prolonged hospitalization in an Intensive Care Unit (ICU), and, among them, critically ill patients who develop acute respiratory failure and need for mechanical ventilation. These individuals have their mobility restricted to bed, and may suffer from pulmonary and systemic complications, such as ICU-Acquired Muscle Weakness, which increases the chances of resulting in reduced functional capacity or death. Early mobilization in the ICU has demonstrated benefits, but still with a low level of evidence. However, the type and intensity of exercise still need to be better defined, and previous protocols did not offer continuous monitoring from the ICU to the ward and subsequent outpatient rehabilitation for these patients, which is considered a limitation in some studies.

Objective: To investigate the effects of an early and intensive hospital mobilization and post-hospital rehabilitation program on indicators of functionality, inflammation, cost-effectiveness, and mortality in critically ill patients undergoing invasive mechanical ventilation.

Methods: This is a Blind Randomized Controlled Clinical Trial that will be conducted in the ICUs of the Hospital das Clinicas and the Emergency Unit of the Faculty of Medicine of Ribeirao Preto of the University of São Paulo. Patients of both sexes over 21 years of age who have been under invasive mechanical ventilation for at least 24 hours will be recruited. Patients will be randomized into the Intervention Group (IG), with 30 to 60 minutes of exercise per day, and the Control Group (CG), with 10 minutes of exercise per day, both with the same protocol and based on the ICU Mobility Scale - IMS, with continuity in the ward. After hospital discharge, participants will be allocated to the Guidance Group (GIor and GCor) and the Outpatient Rehabilitation Group (GIreab and GCreab), with functional exercise capacity as the main outcome, assessed by the six-minute walk test (6MWT). Volunteers will be monitored one, three, and six months after hospital discharge. The sample calculation was based on the results of the 6MWT , with a power of 80% for the assessments carried out at the proposing institution (n=206), and with a power of 90% for the multicenter project (n=275), considering a sample loss of 30%. The following will be evaluated: clinical parameters, severity indexes, functionality, lung function and mechanics, functional exercise capacity, mortality, inflammatory markers, energy expenditure, activities of daily living, quality of life, muscle assessment, adherence, barriers and facilitators and cost-effectiveness.

Being tested
Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge
Keywords
Mechanical ventilation, Physiotherapy, Respiratory function, Functional capacity, Rehabilitation, Cost-effectiveness
Medical subject headings
Respiratory Aspiration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital dischargeOther

    During hospitalization in the ICU and ward, you will perform 30 to 60 minutes of exercises per day, according to the IMS scale.

    After hospital discharge, participation in a supervised exercise program twice a week for 8 weeks at the Rehabilitation Center - CER of the Hospital das Clínicas of the Faculty of Medicine of Ribeirão Preto.

Study groups in NCT06405529
Study groupRoleWhat they receive
Control groupNo interventionDuring hospitalization in the ICU and ward, this group will perform a maximum of 10 minutes of exercises of the casual care per day.
Intervention GroupExperimentalDuring hospitalization in the ICU and ward, this group will perform 30 to 60 minutes of exercises per day, according to the IMS scale and the intensive mobilization protocol.
Receives: Other: Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge
Guidance GroupNo interventionAfter hospital discharge, this group will not participate in any supervised exercise session, they will only be instructed by the therapists and receive the exercise booklet from the Rehabilitation Center.
Rehabilitation GroupExperimentalAfter hospital discharge, this group will participate in a supervised exercise program twice a week for 8 weeks at the Rehabilitation Center.
Receives: Other: Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional exercise capacity

    Assessed by the 6-minute walk test

    Measured: Through study completion, an average of 5 year

Secondary outcomes (12)
  1. Clinical parameters

    Hemodynamic data will be evaluated beafore and after the mobilization protocol

    Measured: Through study completion, an average of 5 year

  2. Clinical parameters

    Level of sedation evaluated by the Richmond Agitation-Sedation Scale (RASS). The scale ranges from -4 to +5, from the highest level of agitation to coma.

    Measured: Through study completion, an average of 5 year

  3. Clinical parameters

    Length of stay in the ICU (tICU) and Length of hospital stay (LoS)

    Measured: Through study completion, an average of 5 year

  4. Clinical parameters

    Time on mechanical ventilation (tMV)

    Measured: Through study completion, an average of 5 year

  5. Severity indexes

    Acute Physiologic and Chronic Health Evaluation II Score (APACHE II). This tool assesses the severity of the disease and mortality of patients admitted to the ICU, consisting of 12 variables that include: age, past medical history, as well as clinical and physiological indices.

    Measured: Through study completion, an average of 5 year

  6. Severity indexes

    Sequential Organ Failure Assessment Score (SOFA Score). This tool calculates both the number and severity of organic dysfunction in six organic systems (respiratory, coagulation, hepatic, cardiovascular, renal and neurological).

    Measured: Through study completion, an average of 5 year

  7. Pulmonary function

    Spirometry will be used as a tool to assess the lung function. The test will be performed by every volunteer and the measurement will be done by guidelines of the Brazilian Society of Pulmonology and Phthisiology for lung function tests.

    Measured: Through study completion, an average of 5 year

  8. Pulmonary function

    Impulse oscillometry system (IOS). This test will be perfomed to evaluate the resistance of the respiratory system in accordance with that proposed by Oosteveen (2003).

    Measured: Through study completion, an average of 5 year

  9. Pulmonary function

    Diffusing capacity of the lungs for carbon monoxide (DLCO). This is a pulmonary function test used to assess the lungs' ability to transfer gas from inspired air to the bloodstream. Normal severity slassification is up to 75% of the predicted value.

    Measured: Through study completion, an average of 5 year

  10. Pulmonary function

    Computed tomography (CT). The high-resolution CT technique with low dose of radiation will be used, without the administration of iodinated contrast medium, scanning the entire chest in the caudocranial direction, with volumetric acquisition of 1 mm in thickness during complete inspiration. Quantitative analysis of HRCT images will be performed using the scientific program Yacta version 2.8 (Heussel et al., 2009).

    Measured: Through study completion, an average of 5 year

  11. Mortality

    Measured: Through study completion, an average of 5 year

  12. Cost-effectiveness

    Economic evaluation - Patient and Institution costs

    Measured: 12 months after study completion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2024
  2. Study start1 Jul 2024 (estimated)
  3. Primary completion31 Jan 2025 (estimated)
  4. Study completion31 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
206 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06405529
Sponsor's protocol ID
USP-2024
Status last verified
May 2024
First submitted
7 Jan 2024
Last updated
8 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Gastaldi AC, Biazon TMPC, Basile-Filho A, Dos Santos DO, Tambascio J, Perossi J, Silveira JM, da Silva MG, Wilches-Lunae EC, Usmani O, de Oliveira AS. A protocol for the rehabilitation of patients undergoing mechanical ventilation from the ICU to the post-hospital phase: the MOVE-ICUtoHOME, a multicentre randomised controlled trial. BMJ Open Respir Res. 2026 Aug 20;13(1):e004039. doi: 10.1136/bmjresp-2025-004039.

    PubMed 42624643

Questions about this trial

What is this clinical trial studying?

A study testing Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge in people with Early Mobilization and Physiotherapy, run by University of Sao Paulo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 May 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional exercise capacity (time frame: Through study completion, an average of 5 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06405529, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in